A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...
CEO Alberto Racca showed WWD Trussardi's striking archives and discussed the first steps of the brand, starting with the fall ...
The computer migration was initiated in 2022 following PSEG's acknowledged failures in responding to Tropical Storm Isaias.
Sciences presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial, which is studying ...
Younger children (age group = 5-11 years) are an especially understudied population, with almost no scientific literature ...